School of Medicine, Departments of Pathology and Laboratory Medicine,
Psychiatry, Medical and Molecular Genetics, and Neurology,
Indiana University, Indianapolis
Dr. Ghetti earned his doctorate in medicine (cum laude) in 1966 and then completed the School of Specialization in Mental and Nervous Diseases (cum laude) in 1969 at the Medical School at the University of Pisa, Pisa, Italy.
He received two postdoctoral research fellowship grants allowing him to study in the United States at the Albert Einstein College of Medicine, Bronx, N.Y. (1970-1973) and then he was a resident in pathology and neuropathology from 1973-1976. In 1976, he became an Assistant Professor of Pathology at Indiana University School of Medicine. By 1978 he became an Associate Professor and in 1983 full Professor.
Since 1991, he has been the Director of the Indiana Alzheimer Disease Center, one of 29 Alzheimer Disease Centers funded by the NIA. He holds joint appointments in the Departments of Pathology and Laboratory Medicine, Psychiatry, Medical and Molecular Genetics, and Neurology. In 1997, he was appointed to the rank of Distinguished Professor.
He has received the Javits Neuroscience Investigator Award (1992-1999) and the Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases (1999) and he was the 58th President of the American Association of Neuropathologists (1996-1997). In 2003 he received the award for Meritorious Contribution to Neuropathology of the American Association of Neuropathologists. In 2005, he received a Laurea Honoris Causa (honorary doctorate in medicine) from the University of Siena.
Throughout his career he has contributed to the understanding
of the causes and mechanisms of neurodegenerative diseases in both
humans and animals. In the field of human diseases, his contributions
are evident by the fact that he and his collaborators have played an
important role in the discovery of novel clinical and pathologic
phenotypes, linking each phenotype to its relevant gene and then
identifying the specific genetic mutations. Such mutations are in the
DNA coding for three of the most significant proteins involved in the
neurodegenerative process of presenile and senile dementias, namely
APP, PrP and Tau. Recently he has studied forms of presenile dementias
associated with mutations in Presenilin 1, Neuroserpin, Ferritin Light
Polypeptide genes. In the field of animal diseases, his research
contributions have spanned from the study of neurological mutant mice,
such as the weaver and pcd, to the transgenic mice carrying mutant
genes, APP, Tau and PrP.
Office: (317) 274-7818; Fax: (317) 274-4882; E-mail: email@example.com